Patents expiring in 2035

US 8999982

Pharmaceutically active compounds as Axl inhibitors

Lead Discovery Center GmbH · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8999705

Bifidobacterial gene sequences and their use

The Regents of the University of California · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8999352

Genetically engineered swine influenza virus and uses thereof

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8999336

Monoclonal antibodies against Orthopoxviruses

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8999290

Papillomavirus pseudoviruses for detection and therapy of tumors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9000131

Antibodies that neutralize botulinum neurotoxins

The Regents of the University of California · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8999934

Treatment of astrocytes-tumor cells inhibitors of endothelin receptors

The Board of Regents of the University of Texas System · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9000191

Serotonin reuptake inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9000141

Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8999988

Protein kinase inhibitors

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9000020

Linked dibenzimidazole antivirals

Enanta Pharmaceuticals, Inc. · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9006283

Methods of modifying amyloid β oligomers using non-peptidic compounds

Acumen Pharmaceuticals, Inc. · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9006201

Prophylactic or therapeutic agent for diabetes

Takeda Pharmaceutical Company Limited · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9005617

Antikine antibodies that bind to multiple CC chemokines

REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9005632

Compositions, methods and uses for poxvirus elements in vaccine constructs against influenza virus subtypes or strains

Takeda Vaccines, Inc. · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9005633

Psoralen-inactivated viral vaccine and method of preparation

United States of America as represented by the Secretary of the Air Force · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9005161

Drug releasing coatings for medical devices

Lutonix, Inc. · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9005582

Hyperthermia therapeutic agent delivery system

UNITED ARAB EMIRATES UNIVERSITY · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9005604

Aligned and electrospun piezoelectric polymer fiber assembly and scaffold

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9006203

Method of reducing inflammatory infiltration in subjects with inflammatory lung disease

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9006219

Oligomer-foscarnet conjugates

Nektar Therapeutics · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9006197

Compositions and methods for inhibiting expression of Eg5 and VEGF genes

Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9006462

Glycopyrrolate salts

Dermira, Inc. · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9006399

Anti-OX40 antibodies and methods of using the same

The Board of Regents of the University of Texas System · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9008184

Multiple sign bit hiding within a transform unit

BlackBerry Limited · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9006473

Nitrated lipids and methods of making and using thereof

University College Cardiff Consultants Limited · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9005964

Endodermal progenitor cells

Regents of the University of Minnesota · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9006222

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9005649

Methods for making controlled delivery devices having zero order kinetics

The Board of Regents of the University of Texas System · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9005648

Inorganically surface-modified polymers and methods for making and using them

The Regents of the University of California · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9005631

Membrane proximal region of HIV gp41 anchored to the lipid layer of a virus-like particle vaccine

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9005185

Nanochanneled device and related methods

The Board of Regents of the University of Texas System · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9005599

Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents

Tissue Regeneration Therapeutics Inc. · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9005638

Cosmetics containing a multi-functional composite powder

JGC Catalysts and Chemicals Ltd. · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9006239

2-aryl-4-quinazolinones and their pharmaceutical compositions

China Medical University · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9006290

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9011874

Compositions, methods and uses for poxvirus elements in vaccine constructs

Takeda Vaccines, Inc. · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9012647

Nitroxide modified non-steroidal anti-inflammatory compounds and uses thereof in the treatment and prevention of diseases or disorders

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9012618

Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structures

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9012467

Compositions for intratumoral administration

Covidien LP · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9012447

5-HT3 receptor antagonists

Takeda Pharmaceutical Company Limited · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9012223

Methods for enhancing genome stability and telomere elongation in embryonic stem cells

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9011913

Use of functionalized magnetic nanoparticles in cancer detection and treatment

The Regents of the University of California · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9011857

Methods of treating cancer by administering EMP2 antibodies

The Regents of the University of California · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9011834

Compositions and methods

Seres Health, Inc. · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9011844

Human cystathionine β-synthase variants and methods of production thereof

The Regents of the University of Colorado, a Body Corporate · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9011926

Method for producing granules

Takeda Pharmaceutical Company Limited · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9011888

Organic-inorganic composite particles, process for producing the same, dispersion containing the particles, and cosmetic containing the particles

JGC Catalysts and Chemicals Ltd. · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)